Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease.

Br J Haematol

Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Published: October 2021

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.17702DOI Listing

Publication Analysis

Top Keywords

neuroprotection evidence
4
evidence early
4
early universal
4
universal hydroxyurea
4
hydroxyurea children
4
children sickle
4
sickle cell
4
cell disease
4
neuroprotection
1
early
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!